CompletedNCT06943703
Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma
Studying Isolated rare lymphatic malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Children's Hospital, Vietnam
- Principal Investigator
- Quang T Nguyen, M.D.Department of Pediatric Surgery, The National Hospital of Pediatrics, Hanoi, Vietnam
- Intervention
- Sclerotherapy with intralesional bleomycin injection(drug)
- Enrollment
- 809 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2025
Study locations (1)
- Department of Surgery, The National Children Hospital, Hanoi, Hanoi, Vietnam
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06943703 on ClinicalTrials.gov